Maggie Flanagan LeFlore

Consumer Services

Health Technology

Finance

Profile

Maggie Flanagan LeFlore worked as a Managing Director at MedImmune Ventures, Inc. from 2007 to 2010.
She also worked as a Director at Astria Therapeutics, Inc. and NKT Therapeutics, Inc. In terms of education, she earned a doctorate degree from Indiana University and an undergraduate degree from the University of Kansas.

Former positions of Maggie Flanagan LeFlore

Companies	Position	End
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.	Private Equity Investor	29/03/2010
ASTRIA THERAPEUTICS, INC.	Director/Board Member	-
NKT Therapeutics, Inc. NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA.	Director/Board Member	-

See the detail of Maggie Flanagan LeFlore's experience

Training of Maggie Flanagan LeFlore

University of Kansas	Undergraduate Degree
Indiana University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Maggie Flanagan LeFlore's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ASTRIA THERAPEUTICS, INC.	Health Technology

Private companies	2
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.	Finance
NKT Therapeutics, Inc. NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA.	Health Technology

See company connections